Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

269

HTML

2776

Figures (1-2)

198

Tables (1-6)

194

Sum=3437

Aug 14, 2005 (publication date) through Nov 14, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Helicobacter Pylori

World J Gastroenterol. Aug 14, 2005; 11(30): 4715-4720
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4715

Table 2 Prevalence rate of H pylori infection and anti-parietal cell antibodies among various groups of patients

¹HC: healthy control; ²DU: duodenal ulcer; ³GU: gastric ulcer; ⁴GC: gastric cancer;

⁵APCA: anti-parietal cell antibodies.

^aP < 0.05 vs healthy control group.

Citation: Lo CC, Hsu PI, Lo GH, Lai KH, Tseng HH, Lin CK, Chan HH, Tsai WL, Chen WC, Peng NJ. Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol 2005; 11(30): 4715-4720
URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4715.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4715